139290-73-6

Basic information

• Product Name: (2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate Salt
• Synonyms: (2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate Salt;(2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate;(2,3-DiMethoxyphenyl)-4-piperidinylMethanone Trifluoroacetic Acid Salt
• CAS NO: 139290-73-6
• Molecular Formula: C₂HF₃O₂*C₁₄H₁₉NO₃
• Molecular Weight: 363.3289096
• Product Categories: Amines;Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Amines, Aromatics, Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 139290-73-6.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• Solubility: Dimethylformamide, DMSO
• CAS DataBase Reference: (2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate Salt(CAS DataBase Reference)
• NIST Chemistry Reference: (2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate Salt(139290-73-6)
• EPA Substance Registry System: (2,3-Dimethoxyphenyl)-4-piperidinylmethanone Trifluoroacetate Salt(139290-73-6)

Safety Data

• Hazardous Substances Data: 139290-73-6(Hazardous Substances Data)

Usage

Chemical Properties

White Solid

Uses

An intermediate in the preparation of serotonin 5-HT2a receptor antagonists

Upstream product

• 139290-70-3 tert-butyl 4-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate 
• 76-05-1 trifluoroacetic acid 
• 139290-71-4 4-(2,3-Dimethoxybenzoyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester 

Downstream Products

• 139290-72-5 (2,3-dimethoxyphenyl)(piperidin-4-yl)methanone 
• 252364-39-9 4-[1-oxo-1-(2,3-dimethoxyphenyl)methyl]-N-2-(4-fluorophenylethyl)piperidine 

Relevant articles and documents

DEUTERATED FORMS AND DERIVATIVES OF VOLINANSERIN

Deuterated forms of volinanserin according to structural formula (I), and their pharmaceutically acceptable salts, pharmaceutical compositions containing these compounds, and methods of treatment or prevention using these compounds or pharmaceutical compositions are described. The compounds are useful for treating or preventing a disease or condition selected from psychosis, schizophrenia, schizoaffective disorder, Parkinson's disease, Lewy body dementia, sleep disorder (including insomnia), agitation, mood disorder (including depression), thromboembolic disorder, autism, and attention deficit hyperactivity disorder.